Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Drug Resistance

  Free Subscription


3 Antimicrob Agents Chemother
3 Clin Infect Dis
2 Infect Control Hosp Epidemiol
5 Int J Antimicrob Agents
1 J Antimicrob Chemother
4 J Med Microbiol
1 PLoS Comput Biol
8 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antimicrob Agents Chemother

  1. JIANG S, Zhuang H, Zhu F, Wei X, et al
    The role of mprF mutations in "see-saw effect" of Daptomycin-resistant methicillin-resistant Staphylococcus aureus isolates.
    Antimicrob Agents Chemother. 2021 Oct 18:AAC0129521. doi: 10.1128/AAC.01295.
    PubMed         Abstract available

  2. DEMCZUK W, Martin I, Griffith A, Lefebvre B, et al
    Linear regression equations to predict beta-lactam, macrolide, lincosamide and fluoroquinolone minimum inhibitory concentrations from molecular antimicrobial resistance determinants in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2021 Oct 18:AAC0137021. doi: 10.1128/AAC.01370.
    PubMed         Abstract available

  3. KARLOWSKY JA, Hackel MA, Sahm DF
    In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales.
    Antimicrob Agents Chemother. 2021 Oct 18:AAC0130421. doi: 10.1128/AAC.01304.
    PubMed         Abstract available

    Clin Infect Dis

  4. ARZIKA AM, Maliki R, Abdou A, Mankara AK, et al
    Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial.
    Clin Infect Dis. 2021;73:1292-1295.
    PubMed         Abstract available

  5. PYNGOTTU A, Scherrer AU, Kouyos R, Huber M, et al
    Predictors of virological failure and time to viral suppression of first line integrase inhibitor based antiretroviral treatment.
    Clin Infect Dis. 2020 Oct 24. pii: 5937176. doi: 10.1093/cid/ciaa1614.
    PubMed         Abstract available

  6. CROWELL TA, Danboise B, Parikh A, Esber A, et al
    Pre-Treatment and Acquired Antiretroviral Drug Resistance among Persons Living with HIV in Four African Countries.
    Clin Infect Dis. 2020 Aug 12. pii: 5891786. doi: 10.1093/cid/ciaa1161.
    PubMed         Abstract available

    Infect Control Hosp Epidemiol

  7. SERRA-BURRIEL M, Campillo-Artero C, Agodi A, Barchitta M, et al
    Association between antibiotic resistance in intensive care unit (ICU)-acquired infections and excess resource utilization: Evidence from Spain, Italy, and Portugal.
    Infect Control Hosp Epidemiol. 2021 Oct 18:1-8. doi: 10.1017/ice.2021.
    PubMed         Abstract available

  8. ALHMIDI H, Cadnum JL, Wilson BM, Donskey CJ, et al
    Transfer of methicillin-resistant Staphylococcus aureus by fist bump versus elbow bump.
    Infect Control Hosp Epidemiol. 2021 Oct 18:1-3. doi: 10.1017/ice.2021.
    PubMed         Abstract available

    Int J Antimicrob Agents

  9. MEI CY, Wu H, Wang Y, Wang ZY, et al
    First detection of the multiresistance gene cfr in Escherichia coli from retail vegetables, China.
    Int J Antimicrob Agents. 2021;57:106348.

  10. MBHELE N, Chimukangara B, Gordon M
    HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance.
    Int J Antimicrob Agents. 2021;57:106343.
    PubMed         Abstract available

  11. WANG X, Ling Z, Sun N, Liu Y, et al
    Molecular genetic characteristics of mcr-9-harbouring Salmonella enterica serotype Typhimurium isolated from raw milk.
    Int J Antimicrob Agents. 2021;57:106332.
    PubMed         Abstract available

  12. NGUYEN HT, Venter H, Veltman T, Williams R, et al
    In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens.
    Int J Antimicrob Agents. 2021;57:106323.
    PubMed         Abstract available

  13. MUSHTAQ S, Garello P, Vickers A, Woodford N, et al
    Cefepime/tazobactam compared with other tazobactam combinations against problem Gram-negative bacteria.
    Int J Antimicrob Agents. 2021;57:106318.
    PubMed         Abstract available

    J Antimicrob Chemother

  14. HUANG Y, Rana AP, Wenzler E, Ozer EA, et al
    Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021 Oct 20. pii: 6403927. doi: 10.1093.
    PubMed         Abstract available

    J Med Microbiol

  15. EL-SHEIKH SMA, Abd El-Alim AEF, Ibrahim HA, Mobarez EA, et al
    Chitosan propolis nanocomposite alone or in combination with apramycin: an alternative therapy for multidrug-resistant Salmonella Typhimurium in rabbits: in vitro and in vivo study.
    J Med Microbiol. 2021;70.
    PubMed         Abstract available

  16. MATSUMOTO T, Matsumoto-Matsubara M, Horiuchi K, Arai E, et al
    Antibiotic resistance and the presence of bla CfxA and bla CSP genes in beta-lactamase-producing clinical Capnocytophaga isolates from a university hospital in Japan.
    J Med Microbiol. 2021;70.
    PubMed         Abstract available

  17. HIGASHINO HR, Marchi AP, Ruedas Martins RC, Bubach Carvalho L, et al
    Carbapenem-resistant Klebsiella pneumoniae colonization and infection is associated with lower overall survival in a cohort of haematopoietic stem-cell transplantation patients: mechanism of resistance and virulence by whole-genome sequencing.
    J Med Microbiol. 2021;70.
    PubMed         Abstract available

  18. SULTAN AM, Amer GF, Nabiel Y
    Quinolone-resistant uropathogenic E. coli: is there a relation between qnr genes, gyrA gene target site mutation and biofilm formation?
    J Med Microbiol. 2021;70.
    PubMed         Abstract available

    PLoS Comput Biol

  19. ESENER N, Guerra AM, Giebel K, Lea D, et al
    Mass spectrometry and machine learning for the accurate diagnosis of benzylpenicillin and multidrug resistance of Staphylococcus aureus in bovine mastitis.
    PLoS Comput Biol. 2021;17:e1009108.
    PubMed         Abstract available

    PLoS One

  20. LENDAK D, Puerta-Alcalde P, Moreno-Garcia E, Chumbita M, et al
    Changing epidemiology of catheter-related bloodstream infections in neutropenic oncohematological patients.
    PLoS One. 2021;16:e0251010.
    PubMed         Abstract available

  21. WILKINSON LV, Alford MA, Coleman SR, Wu BC, et al
    Peptide 1018 inhibits swarming and influences Anr-regulated gene expression downstream of the stringent stress response in Pseudomonas aeruginosa.
    PLoS One. 2021;16:e0250977.
    PubMed         Abstract available

  22. WANGMO K, Dorji T, Pokhrel N, Dorji T, et al
    Knowledge, attitude, and practice on antibiotic use and antibiotic resistance among the veterinarians and para-veterinarians in Bhutan.
    PLoS One. 2021;16:e0251327.
    PubMed         Abstract available

  23. GEBEYEHU DT, Bekele D, Mulate B, Gugsa G, et al
    Knowledge, attitude and practice of animal producers towards antimicrobial use and antimicrobial resistance in Oromia zone, north eastern Ethiopia.
    PLoS One. 2021;16:e0251596.
    PubMed         Abstract available

  24. KHALID A, Ahmad P, Alharthi AI, Muhammad S, et al
    Synergistic effects of Cu-doped ZnO nanoantibiotic against Gram-positive bacterial strains.
    PLoS One. 2021;16:e0251082.
    PubMed         Abstract available

  25. DOIDGE C, Lima E, Lovatt F, Hudson C, et al
    From the other perspective: Behavioural factors associated with UK sheep farmers' attitudes towards antibiotic use and antibiotic resistance.
    PLoS One. 2021;16:e0251439.
    PubMed         Abstract available

  26. SANCHEZ-CORRALES L, Tovar-Aguirre OL, Galeano-Vanegas NF, Castano Jimenez PA, et al
    Phylogenomic analysis and Mycobacterium tuberculosis antibiotic resistance prediction by whole-genome sequencing from clinical isolates of Caldas, Colombia.
    PLoS One. 2021;16:e0258402.
    PubMed         Abstract available

  27. HERMAN B, Sirichokchatchawan W, Pongpanich S, Nantasenamat C, et al
    Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia.
    PLoS One. 2021;16:e0249243.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.